孕前25-羟基维生素D(25(OH)D)与生育力
该基于社区的前瞻性队列研究纳入2010至2016年间522名尝试怀孕女性,发现孕前25(OH)D每升高10 ng/ml生育力估计提高10%(FR 1.10,95%CI 0.96-1.25),但估计不精确;高25(OH)D(至少50 ng/ml)与生育力升高、低25(OH)D(<20 ng/ml)与生育力降低呈提示性关联。
要点
- 孕前25(OH)D每升高10 ng/ml,生育力估计提高10%(FR 1.10,95%CI 0.96-1.25)。
- 与25(OH)D 30-40 ng/ml相比,<20 ng/ml者生育力估计降低45%(FR 0.55,95%CI 0.23-1.32)。
- 与25(OH)D 30-40 ng/ml相比,至少50 ng/ml者生育力估计升高35%(FR 1.35,95%CI 0.95-1.91)。
核心结论
- 高25(OH)D(至少50 ng/ml)与生育力升高、低25(OH)D(<20 ng/ml)与生育力降低呈提示性关联,但估计不精确。
- 研究结果与既往关于25(OH)D低于临床定义缺乏水平(20 ng/ml)的女性生育力降低的报告一致。
- 需要进一步研究评估显著更高25(OH)D浓度(>50 ng/ml)可能的生殖获益。
研究设计与样本
- 基于社区的前瞻性队列研究,纳入2010至2016年间522名尝试怀孕女性。
- 研究对象来自北卡罗来纳州中部,年龄30-44岁,无不孕史,招募时尝试时间不超过3个月。
- 女性完成在线每日和每月日记,直至观察到家庭妊娠试验阳性或满12个月。
主要发现
- 522名女性中257名在研究期间怀孕,平均年龄33岁,平均25(OH)D为36 ng/ml。
- 25(OH)D每升高10 ng/ml,生育力估计提高10%(FR 1.10,95%CI 0.96,1.25)。
- 与25(OH)D 30-40 ng/ml相比,<20 ng/ml者生育力估计降低45%(FR 0.55,95%CI 0.23,1.32)。
- 与25(OH)D 30-40 ng/ml相比,至少50 ng/ml者生育力估计升高35%(FR 1.35,95%CI 0.95,1.91)。
- 25(OH)D <20 ng/ml、30-40 ng/ml和>50 ng/ml三组中,尝试受孕超过6个月的概率分别为51%(17%,74%)、28%(17%,39%)和15%(10%,37%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 虽然25(OH)D分布较宽,但高25(OH)D(N=107)或低25(OH)D(N=56)的观察周期数较少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is pre-conception 25(OH)D associated with the per cycle probability of conception, i.e fecundability, in a prospective cohort study? SUMMARY ANSWER: There are suggestive associations of high 25(OH)D (at least 50 ng/ml) with increased fecundability and low 25(OH)D (<20 ng/ml) with reduced fecundability, but the estimates were imprecise. WHAT IS KNOWN ALREADY: Vitamin D has been associated with reproductive function and fertility in animal studies, but few human studies exist. STUDY DESIGN, SIZE, DURATION: This community-based prospective cohort study included 522 women attempting to become pregnant between 2010 and 2016. The women completed online daily and monthly diaries until a positive home pregnancy test was observed or 12 months had elapsed. PARTICIPANTS/MATERIALS, SETTING, METHODS: The study included women from central North Carolina who were aged 30-44 with no history of infertility, with no more than 3 months of attempt time at recruitment. Women recorded vaginal bleeding so that the ongoing number of attempt cycles could be counted and used to quantify a woman's pregnancy attempt time. Blood collected at the study entry was analysed for 25(OH)D using liquid chromatography tandem mass spectrometry. Associations with fecundability were estimated with a log-binomial discrete time-to-event model. MAIN RESULTS AND THE ROLE OF CHANCE: Among 522 women, 257 conceived during the study. The mean age was 33 years and the mean 25(OH)D was 36 ng/ml. There was an estimated 10% higher fecundability with each 10 ng/ml increase in 25(OH)D (fecundability ratio (FR) 1.10, 95% CI: 0.96, 1.25). The suggestive dose-response association with the continuous measure of 25(OH)D was driven by women in the lowest and the highest categories of 25(OH)D. Compared to women with 25(OH)D of 30-40 ng/ml, women below 20 ng/ml had an estimated 45% reduction in fecundability (FR (CI): 0.55 (0.23, 1.32)), and women with at least 50 ng/ml had an estimated 35% increase in fecundability (FR (CI): 1.35 (0.95, 1.91)). Across these three categories (25(OH)D of <20 ng/ml, 30-40 ng/ml and > 50 ng/ml), the probability of taking longer than 6 months to conceive was, respectively, 51% (17%, 74%), 28% (17%, 39%) and 15% (10%, 37%). LIMITATIONS, REASONS FOR CAUTION: While the distribution of 25(OH)D was wide, the number of observed cycles with high 25(OH)D (N = 107) or low 25(OH)D (N = 56) was small. WIDER IMPLICATIONS OF THE FINDINGS: Our findings are consistent with prior reports of reduced fertility in women with 25(OH)D concentrations below the clinically defined deficiency level (20 ng/ml). Further studies are needed to evaluate the possible reproductive benefits of considerably higher 25(OH)D concentration (>50 ng/ml). STUDY FUNDING/COMPETING INTEREST(S): This research was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (NIH) under award numbers R00HD079659 and R01HD067683 and supported in part by the Intramural Research Program of the National Institute of Environmental Health Sciences, under projects ES103086, ES049003 and ES044003. ClearBlue ovulation predictor kits were generously donated to AMZJ and AJW by Swiss Precision Diagnostics. Drs Wilcox and Jukic report non-financial support from Swiss Precision Diagnostics during the conduct of the study; Dr Jukic reports non-financial support from Theralogix, LLC, outside the submitted work. Otherwise there are no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Jukic AMZ, Baird DD, Weinberg CR, et al. Pre-conception 25-hydroxyvitamin D (25(OH)D) and fecundability. Hum Reprod. 2019. PMID: 31665286. doi:10.1093/humrep/dez170
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。